Dr. Barry S. Berman, MD

Dr. Berman practices at Good Samaritan Medical Center in West Palm Beach, Florida, part of Tenet Healthcare.

Dr. Berman's NPI, 1578556098, was assigned on August 30, 2005. Dr. Berman graduated from USF Health Morsani College of Medicine in 1988. Dr. Berman holds Florida license ME56669.

Dr. Berman's primary practice is Good Samaritan Medical Center, at 1309 N Flagler Dr, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (561) 655-5511.

Dr. Berman's primary practice is Good Samaritan Medical Center in West Palm Beach, Florida, part of Tenet Healthcare. Dr. Berman is also affiliated with Wellington Regional Medical Center. The medical group on file is Florida Cancer Specialists & Research Institute.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berman practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Berman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Berman is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Berman's licenses on file in 4 states: Florida, Georgia, Tennessee and Virginia.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphedema among the conditions Dr. Berman treats.

CMS data shows 39,514 Medicare services from Dr. Berman across 44 procedure codes in 2024, for 571 Medicare patients. Medicare paid $626,082 for them.

CMS counts 571 Medicare patients who saw Dr. Berman in 2024. The largest group is 75 to 84, with 239 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berman's median patient age at 62, with 66% women.

In 2024, Dr. Berman wrote 1,658 Medicare Part D claims for 216 patients. 68% of them were for generic drugs. CMS names the drug for 1,238 of them, across 44 drugs with 11 or more claims each, at $4,067,299 in total drug cost. In 2023, CMS named 1,072 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Berman for performance year 2024, reported as part of a group. Dr. Berman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berman as offering telehealth.

Dmand AI links 6 papers to Dr. Berman, published from 2014 to 2023. 2014 was the busiest year, with 2. The most frequent topics are Anxiety and Depression. Dr. Berman has published most often in J Clin Oncol. Dr. Berman's most frequent co-authors are Stephen Patrick Anthony, DO, Jonathan Samuel Berek, MD and Natasha Nichole Bray, DO.

Dmand AI links Dr. Berman to 1 clinical trial. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 1,544 general payments to Dr. Berman from 102 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Millennium Pharmaceuticals, Inc. paid the most, $4,879.

Dr. Berman graduated from USF Health Morsani College of Medicine in 1988. Dr. Berman is a member of ASCO.

Dr. Berman is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.